Tissue-based assay for ornithine decarboxylase to identify patients likely to respond to difluoromethylornithine.

about

CNS Anticancer Drug Discovery and Development Conference White Paper.Helicobacter pylori CagA induces ornithine decarboxylase upregulation via Src/MEK/ERK/c-Myc pathway: implication for progression of gastric diseases.

P2860

Q36089590-78B2A06B-0AAC-4AFA-B55E-9BB787332237 Q54521768-BC557D28-FA52-474E-9DCB-EB0112C9F546

P2860

Tissue-based assay for ornithine decarboxylase to identify patients likely to respond to difluoromethylornithine.

Item

http://www.wikidata.org/entity/Q38324120

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Tissue-based assay for ornithi ...... nd to difluoromethylornithine.

@en

type

Item

label

Tissue-based assay for ornithi ...... nd to difluoromethylornithine.

@en

prefLabel

Tissue-based assay for ornithi ...... nd to difluoromethylornithine.

@en

P1476

Tissue-based assay for ornithi ...... ond to difluoromethylornithine

@en

P2093

Anthony E Pegg

http://www.w3.org/2001/XMLSchema#string

Jacob L Jochec

http://www.w3.org/2001/XMLSchema#string

Patricia E Koch

http://www.w3.org/2001/XMLSchema#string

Victor A Levin

http://www.w3.org/2001/XMLSchema#string

P2860

Translocation of ornithine decarboxylase to the surface membrane during cell activation and transformation

Targeted overexpression of ornithine decarboxylase enhances beta-adrenergic agonist-induced cardiac hypertrophy

Polyamine metabolism in brain tumours: diagnostic relevance of quantitative biochemistry

Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.

Phase I-II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumors.

The WHO classification of tumors of the nervous system.

Prostate cancer prevention: review of target populations, pathological biomarkers, and chemopreventive agents.

Prostate cancer prevention strategies using antiproliferative or differentiating agents.

Regulation of ornithine decarboxylase mRNA levels in human breast cancer cells: pattern of expression and involvement of core enhancer promoter element.

Tissue microarrays: applications in neuropathology research, diagnosis, and education.

P304

1467-1474

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1369/JHC.4A6358.2004

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lisa M Shantz

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15505341

http://www.w3.org/2001/XMLSchema#string

P932

3957822

http://www.w3.org/2001/XMLSchema#string

Tissue-based assay for ornithine decarboxylase to identify patients likely to respond to difluoromethylornithine.

about

P2860

P2860

Tissue-based assay for ornithine decarboxylase to identify patients likely to respond to difluoromethylornithine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932